Oral candidiasis in non-severe COVID-19 patients: call for antibiotic stewardship
Status PubMed-not-MEDLINE Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
33042219
PubMed Central
PMC7537301
DOI
10.1111/ors.12561
PII: ORS12561
Knihovny.cz E-zdroje
- Klíčová slova
- COVID‐19, antimicrobial stewardship, candidiasis, oral manifestations, tongue,
- Publikační typ
- časopisecké články MeSH
Zobrazit více v PubMed
Riad A, Klugar M, Krsek M. COVID‐19 related oral manifestations, early disease features? Oral Dis 2020; 10.1111/odi.13516. PubMed DOI PMC
Salehi M, Ahmadikia K, Mahmoudi S, Kalantari S, Jamalimoghadamsiahkali S, Izadi A et al. Oropharyngeal candidiasis in hospitalised COVID‐19 patients from Iran: species identification and antifungal susceptibility pattern. Mycoses 2020;63:771–8. 10.1111/myc.13137. PubMed DOI PMC
Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D et al. The CARE guidelines: consensus‐based clinical case reporting guideline development. BMJ Case Rep. 2013;2013: 10.1136/bcr-2013-201554. PubMed DOI PMC
Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M et al. Bacterial and fungal co‐infection in individuals with coronavirus: a rapid review to support COVID‐19 antimicrobial prescribing. Clin Infect Dis 2020; 10.1093/cid/ciaa530. PubMed DOI PMC
Dziedzic A, Wojtyczka R. The impact of coronavirus infectious disease 19 (COVID‐19) on oral health. Oral Dis 2020; 10.1111/odi.13359. PubMed DOI PMC
COVID-19-Associated Mucormycosis (CAM): Case-Series and Global Analysis of Mortality Risk Factors
Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers
Oral candidiasis of COVID-19 patients: Case report and review of evidence
Prevalence of COVID-19 Vaccine Side Effects among Healthcare Workers in the Czech Republic
Oral Complications of ICU Patients with COVID-19: Case-Series and Review of Two Hundred Ten Cases